FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/03/2025
Back to search
Official data from USPTO
CAPDRIVE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
04/03/2026
Trademark type
Combined
Nice classes
5, 42
Filing date
03/02/2023
Registration date
11/12/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/12/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
CN
Examiner
CARROLL, DORITT
Law office
M70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Skyline Therapeutics (Shanghai) Co.,Ltd.
Representatives
Michael T. Smith Birch Stewart Kolasch & Birch LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Stem cells for medical purposes; biochemical medicine for the treatment of ophthalmicneurologicalcardiovascularmetabolic diseases; biological preparations for medical purposesfor the treatment of ophthalmicneurologicalcardiovascularmetabolic diseases; biological tissue cultures for medical purposes; chemical preparations for medical purposesfor the treatment of ophthalmicneurologicalcardiovascularmetabolic diseases; chemical preparations for pharmaceutical purposesfor the treatment of ophthalmicneurologicalcardiovascularmetabolic diseases; chemico-pharmaceutical preparations for the treatment of ophthalmicneurologicalcardiovascularmetabolic diseases; drugs for medical purposespharmaceutical preparations for the treatment of ophthalmicneurologicalcardiovascularmetabolic diseases; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the central nervous system; ophthalmological preparations; pharmaceutical preparations for the treatment of immune system related diseases and disorders; cardiovascular agents for medical purposes; cellular function activating agents for medical purposes; pharmaceutical products for the prevention and treatment of cancer
Class 42
Scientific research and development; scientific research; technological researchresearch on the subject of pharmaceuticals; biological research; scientific research in the nature of conducting clinical trials for others; medical research; pharmaceutical research services; research on the subject of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; structural and functional analysis of genomes; biotechnology research; analysis of the mode of action of chemical combinations on animals; research and development services in the field of antibodies; genetic testing for scientific research purposes; biological research and analysis; pharmaceutical drug development services; DNA screening for scientific research purposes; medical research; testing of pharmaceuticals; biomedical research services
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/11/2025
FIMP
FINAL DISPOSITION PROCESSED
04/11/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/12/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/12/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
11/12/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/09/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/23/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
10/23/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/27/2024
PUBO
PUBLISHED FOR OPPOSITION
08/27/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/22/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/19/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/19/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/19/2024
RFNT
REFUSAL PROCESSED BY IB
02/14/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/19/2024
RFRR
REFUSAL PROCESSED BY MPU
01/19/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/02/2023
CNRT
NON-FINAL ACTION WRITTEN
12/01/2023
DOCK
ASSIGNED TO EXAMINER
12/01/2023
MAFR
APPLICATION FILING RECEIPT MAILED
05/30/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/26/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/25/2023
Continuous trademark protection
Get notified about every new filing that threatens CAPDRIVE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.